Zoekresultaten - 3 results
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
OncoPredict HPV QT (index test) for the detection of CIN2 + was assessed relative to the GP5 +/6+ Enzyme ImmunoAssay (GP5 +/6+ EIA) (comparator test), using noninferiority criteria. Intra- and interlaboratory ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
assay targeting E6 / E7 genes of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...